Tuesday, November 14
Gore Main Pavilion, Mercury Ballroom
Pavilion Opens | 9:00 am
Lunch Symposium
Together. Advancing Vascular Care.
Together. Advancing Vascular Care.
Discover how recent developments are helping physicians make a difference in the lives of patients. This discussion, focused on how we partner with you to solve unique needs in complex cases will feature insights, clinical findings, and case studies across the spectrum of vascular care; from aortic and carotid to peripheral and more.
Mark Farber, MD, Chapel Hill, North Carolina
Claudio Schönholz, MD, Charleston, South Carolina
Discover how recent developments are helping physicians make a difference in the lives of patients. This discussion, focused on how we partner with you to solve unique needs in complex cases, will feature insights, clinical findings, and case studies across the spectrum of vascular care; from aortic and carotid to peripheral and more.
Mark Farber, MD, Chapel Hill, North Carolina
Claudio Schönholz, MD, Charleston, South Carolina
Evening Event | 6:00 pm
Together. Improving Outcomes, Changing Lives.
Together. Improving Outcomes, Changing Lives.
Experience the treatment journeys of complex cases from the perspective of patients and their physicians. This evening features inspirational personal narratives focusing on how our innovative vascular solutions and collaborative partnerships have impacted their treatments and their lives.
Gore Main Pavilion, Mercury Ballroom Off MM/DD/YYYYExperience the treatment journeys of complex cases from the perspective of patients and their physicians. This evening features inspirational personal narratives, focusing on how our innovative vascular solutions and collaborative partnerships have impacted their treatments and their lives.
Wednesday, November 15
Gore Main Pavilion, Mercury Ballroom
Pavilion Opens | 6:00 am
Lunch Symposium
Straight talk from the experts: Examining challenges and controversies in the treatment of complex peripheral disease
Straight talk from the experts: Examining challenges and controversies in the treatment of complex peripheral disease
In the era of “leave nothing behind”, where do bare metal stents continue to play a critical role?
Scott Berman, MD, Tucson, Arizona
Challenges in the treatment of IOD: Why not all balloon expandable stents are created equal.
Darren Schneider, MD, New York City, New York
Combating concerns for thrombosis: Strategies for optimal stent graft outcomes in long SFA lesions.
Darren Schneider, MD, New York City, New York
Gaining ground: Is the performance of prosthetic conduits getting closer to vein?
Peter Lin, MD, Los Angeles, California
- In the era of “leave nothing behind”, where do bare metal stents continue to play a critical role?
Scott Berman, MD, Tucson, Arizona
- Challenges in the treatment of IOD: Why not all balloon expandable stents are created equal
Darren Schneider, MD, New York City, New York
- Combating concerns for thrombosis: Strategies for optimal stent graft outcomes in long SFA lesions
Darren Schneider, MD, New York City, New York
- Gaining ground: Is the performance of prosthetic conduits getting closer to vein?
Peter Lin, MD, Los Angeles, California
Evening Event | 6:00 pm
Pavilion is in-use for invitation only event.
Thursday, November 16
Gore Main Pavilion, Mercury Ballroom
Pavilion Opens | 6:00 am
Lunch Symposium
What are we learning as we evaluate the GORE® TAG® Thoracic Branch Endoprosthesis in a prospective clinical trial?
Dennis Gable, MD, Dallas, Texas
Evaluating the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System: What does early clinical experience tell us about this new device?
Giovanni Torsello, MD, Münster, Germany
What are we learning as we evaluate the GORE® TAG® Thoracic Branch Endoprosthesis in a prospective clinical trial?
Dennis Gable, MD, Dallas, Texas
Evaluating the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System: What does early clinical experience tell us about this new device?
Giovanni Torsello, MD, Münster, Germany
Evening Event | 6:00 pm
Pavilion is in-use for invitation only event.
Friday, November 17
GORE MAIN PAVILION, MERCURY BALLROOM
Pavilion Opens | 6:00 am
Lunch Symposium
Insights from Latin America
Insights from Latin America
Chairman: Pierre Galvagni, MD, Florianópolis, Brazil
Moderators: Bernardo Massiére, MD, Rio de Janeiro, Brazil
Bruno Freitas, MD, Maceió and Leipzig, Brazil and Germany
Endograft treatment demonstrates durable benefits in a 2-year RELINE Trial
Sidnei Galego, MD, São Paulo, Brazil
GORE® VIABAHN® Endoprosthesis demonstrates powerful patency in 20+ cm SFA Lesions
Marcio Miyamotto, MD, Curitiba, Brazil
GORE® VIABAHN® Endoprosthesis in treating stenosis or thrombotic occlusions of a synthetic arteriovenous (AV) access graft at the venous anastomosis
Antonio Henrique de Sousa Quintella, MD, Belo Horizonte, Brazil
Chairman: Pierre Galvagni, MD, Florianópolis, Brazil
Moderators: Bernardo Massiére, MD, Rio de Janeiro, Brazil
Bruno Freitas, MD, Maceió and Leipzig, Brazil and Germany
Endograft treatment demonstrates durable benefits in a 2-year RELINE Trial
Sidnei Galego, MD, São Paulo, Brazil
Clinical observations from Brazil: Evaluating the efficacy of GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface for endovascular treatment of popliteal aneurysms
Guilherme Napp, MD, Porto Alegre, Brazil
GORE® VIABAHN® Endoprosthesis demonstrates powerful patency in 20+ cm SFA Lesions
Marcio Miyamotto, MD, Curitiba, Brazil
GORE® VIABAHN® Endoprosthesis in treating stenosis or thrombotic occlusions of a synthetic arteriovenous (AV) access graft at the venous anastomosis
Antonio Henrique de Sousa Quintella, MD, Belo Horizonte, Brazil
Saturday, November 18
GORE MAIN PAVILION, MERCURY BALLROOM
Pavilion Opens | 6:00 am
Lunch Symposium
How unique dialysis access technologies help optimize patient outcomes
How unique dialysis access technologies help optimize patient outcomes
How early cannulation grafts assist with earlier removal of central venous catheters
Matteo Tozzi, MD, Varese, Italy
Achieving long-term value: How stent grafts impact the treatment of the thrombosed dialysis graft
Scott Berman, MD, Tucson, AZ
A novel approach to hemodialysis access: Using the GORE® Hybrid Vascular Graft in patients with limited access options
Scott Berman, MD, Tucson, AZ
- How early cannulation grafts assist with earlier removal of central venous catheters
Matteo Tozzi, MD, Varese, Italy
- Achieving long-term value: How stent grafts impact the treatment of the thrombosed dialysis graft
Scott Berman, MD, Tucson, AZ
- A novel approach to hemodialysis access: Using the GORE® Hybrid Vascular Graft in patients with limited access options
Scott Berman, MD, Tucson, AZ